|Year : 2013 | Volume
| Issue : 2 | Page : 93-98
|Detection of premalignant bronchial lesions can be significantly improved by combination of advanced bronchoscopic imaging techniques
Bojan Zaric1, Branislav Perin1, Vladimir Stojsic1, Vladimir Carapic1, Jovan Matijasevic2, Ilija Andrijevic2, Zivka Eri1
1 Department of Interventional Pulmonology, Institute for Pulmonary Diseases of Vojvodina, Clinic for Pulmonary Oncology, Sremska Kamenica, Serbia
2 Intensive Care Unit, Institute for Pulmonary Diseases of Vojvodina, Clinic for Urgent Pulmonology, Faculty of Medicine, University of Novi Sad, Sremska Kamenica, Serbia
|Date of Submission||17-Sep-2012|
|Date of Acceptance||12-Dec-2012|
|Date of Web Publication||30-Mar-2013|
Department of Interventional Pulmonology, Institute for Pulmonary Diseases of Vojvodina, Clinic for Pulmonary Oncology, Faculty of Medicine, University of Novi Sad, Put Doktora Goldmana 4, Sremska Kamenica
| Abstract|| |
Background: The search for the most efficient bronchoscopic imaging tool in detection of early lung cancer is still active. The major aim of this study was to determine sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of each bronchoscopic technique and their combination in detection of premalignant bronchial lesions.
Methods: This was a prospective trial that enrolled 96 patients with indication for bronchoscopy. Lesions were classified as visually positive if pathological fluorescence was observed under autofluorescence imaging (AFI) videobronchoscopy or dotted, tortuous, and abrupt-ending blood vessels were identified under narrow band imaging (NBI) videobronchoscopy. Squamous metaplasia, mild, moderate, or severe dysplasia, and carcinoma in situ (CIS) were regarded as histologically positive lesions.
Results: Sensitivity, specificity, PPV, and NPV of white light videobronchoscopy (WLB) in detection of premalignant lesions were 26.5%, 63.9%, 34.4%, and 54.9%, respectively; the corresponding values for AFI were 52%, 79.6%, 64.6%, and 69.9% respectively, for NBI were 66%, 84.6%, 75.4%, 77.7%, respectively, while the values for combination of NBI and AFI were 86.1%, 86.6%, 84.6%, and 88%, respectively. Combination of NBI and AFI significantly improves sensitivity when compared to each individual technique ( P < 0.001). When specificity is of concern, combination of techniques improves specificity of WLB ( P < 0.001) and specificity of AFI ( P = 0.03), but it does not have significant influence on specificity of NBI ( P = 0.53).
Conclusion: Combination of NBI and AFI in detection of premalignant bronchial lesions increases both sensitivity and specificity of each technique. However, it seems that NBI is most sufficient and effective in detection of these lesions.
Keywords: Autofluorescence bronchoscopy, bronchoscopy, interventional pulmonology, lung cancer, narrow band imaging, premalignant lesions
|How to cite this article:|
Zaric B, Perin B, Stojsic V, Carapic V, Matijasevic J, Andrijevic I, Eri Z. Detection of premalignant bronchial lesions can be significantly improved by combination of advanced bronchoscopic imaging techniques. Ann Thorac Med 2013;8:93-8
|How to cite this URL:|
Zaric B, Perin B, Stojsic V, Carapic V, Matijasevic J, Andrijevic I, Eri Z. Detection of premalignant bronchial lesions can be significantly improved by combination of advanced bronchoscopic imaging techniques. Ann Thorac Med [serial online] 2013 [cited 2020 Aug 4];8:93-8. Available from: http://www.thoracicmedicine.org/text.asp?2013/8/2/93/109820
Lung cancer remains one of the most lethal malignancies worldwide, among both men and women. Most important drawbacks in efficient treatment of lung cancer are delayed diagnosis and absence of effective screening. Detection and study of precancerous lesions of the bronchial mucosa might be one of the turning points in understanding of neoplastic transformation, and therefore creation of most effective treatment. ,,,, However, the use of white light videobronchoscopy (WLB) in detection of precancerous lesions yields low sensitivity and specificity. Introduction of narrow band imaging (NBI) and autofluorescence imaging (AFI) videobronchoscopy into diagnostic evaluation of lung cancer significantly improved sensitivity in detection of precancerous lesions. Improvement of specificity is questionable for AFI, but in case of NBI, specificity in detection of early lung cancer might be improved. Large number of clinical studies showed good potential of AFI and NBI in detection of precancerous bronchial lesions. ,,,,,, One of the most important clinical trials on autofluorescence bronchoscopy, Haussinger's study,  did not confirm the value of this technique in screening, but it did point out the value in detection of precancerous lesions in high-risk groups of patients. Both NBI and AFI are now widely used as scientific bronchoscopic tools in detection of early stage lung cancer. However, both are also efficient as tools for evaluation of endobronchially visible tumor, for detection of synchronous tumors, and for follow-up of surgically treated patients. ,,
Effective detection of precancerous lesions is one of the most important premises for their further investigations. Substantial number of clinical studies nowadays confirms the presence of important molecular changes in impaired bronchial epithelium that might be very important for further understanding of carcinogenesis. Evaluation and confirmation of best bronchoscopic optical tools for detection of these changes might therefore be very important for continuation of research on precancerous bronchial lesions. ,,,
AFI is one of the newest charged-couple device (CCD)-based videobronchoscopy systems. It is mainly constructed to detect weak autofluorescent signal from pathologically altered bronchial mucosa. The system successfully detects intraepithelial changes, and thus is successful in detection of squamous cell alterations. On the other hand, NBI is optical enhancement technology designed to detect subepithelial blood vessel grid. This enables NBI to detect all vascular abnormalities. These differences theoretically make the two techniques compatible; while AFI detects epithelial changes NBI captures abnormal subepithelial vascular patterns. That is why the combination of two techniques might be most efficient in detection of precancerous bronchial lesions. ,
Primary aim of this clinical study was to determine sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of each bronchoscopic technique, WLB, AFI, NBI, and their combination in detection of premalignant bronchial lesions. Secondary objectives were determination of sensitivity, specificity, PPV, and NPV of each bronchoscopic technique and their combination for each individual premalignant lesion and determination of the most efficient technique for detection of preinvasive lesions.
| Methods|| |
The study was a prospective, non-randomized trial, conducted at a dedicated respiratory endoscopy unit of a university teaching clinic at the Institute for Pulmonary Diseases of Vojvodina in Serbia in the period from June 2009 to December 2009. It was approved by the institutional review and ethics board. All the patients who decided to participate in the study were informed about the procedure, its potential benefits and the risks, and all of them had signed institutional informed consent form. All the patients screened for the enrollment were previously scheduled for routine bronchoscopy.
Inclusion criteria for enrollment in the study were: age over 18 years, radiological suspicion for lung cancer, surveillance of patients after curative lung cancer surgery, evaluation of known malignancy, positive sputum cytology, and prolonged cough. Exclusion criteria were: patients who did not want to participate in the study, Eastern Cooperative Oncology Group (ECOG) ≥3, recent myocardial infarction, unresolved coagulopathies, unstable angina pectoris, chronic heart failure (New York Heart Association NYHA ≥ 3), uncontrolled arrhythmia or hypertension, and allergy to anesthetics. Prior to the enrollment in the study, all patients must have had chest X-ray, computed tomography (CT) scan of the thorax and abdomen, spirometry and body pletismography, blood gas analysis, complete blood count, and blood biochemistry. One hundred and nineteen patients were screened for the study; 96 of them met all the inclusion criteria and were not having any exclusion criterion.
Technique and design
Bronchoscopy was performed in a dedicated respiratory endoscopy unit by bronchoscopists experienced in the use of AFI and NBI. All procedures were performed in analgosedation. The routine vital parameters were monitored: noninvasive arterial blood pressure, oxygen saturation on pulse oximetry, and ECG for cardiac rhythm. Brochoscopic equipments used in the study were AF videobronchoscope BF-F260 and NBI videobronchoscope BF-1T180 and BF-1TQ180 (Olympus Corporation, Tokyo, Japan), and video processor unit EVIS LUCERA SPECTRUM (CV-260SL) (Olympus Corporation). Videobronchoscopy image was presented at a 19-inch LCD monitor OEV-191. The examination of the tracheobronchial tree started with WLB followed by NBI and AFI. All the suspected changes in bronchial mucosa were first examined with the WLB, followed by NBI and AFI modes. Once the pathologic sites were identified, we performed targeted biopsies in order to obtain material for pathological examination. A dedicated lung pathologist evaluated the biopsy specimens, blinded to bronchoscopic findings. In all patients, at least one but no more than three biopsies were taken from places identified as pathologic, either by WLB, AFI, NBI, or their combination. One to three random biopsies were taken from the places identified as normal. ,,, Visually pathologic areas under AFI were defined as reddish-brown or magenta-colored area, while the healthy area was green. Visual scoring system for detection of pathologically altered mucosal areas under AFI is given in [Table 1].
|Table 1: Visual appearance of normal and pathologically altered mucosa under autofluorescence videobronchoscopy|
Click here to view
Visually pathologic areas under NBI were defined as dotted, tortuous, or abrupt-ending blood vessels. Dotted, abrupt-ending, and tortuous blood vessels as defined by Shibuya, and commonly known as Shibuya descriptors, were denominators for visual detection of pathological areas under NBI videobronchoscopic examination.  Visually positive areas in combined mode (NBI + AFI) were confirmed if the area of the mucosa was clearly pathological under both techniques. ,,, Each targeted biopsy specimen was obtained by a separate dedicated forceps (usually FB-19C-1 or FB-15C-1). Biopsies were identified as positive if squamous metaplasia, dysplasia, or invasive carcinoma was identified in the tissue. If needed, for confirmation of the disease, additional transbronchial biopsies (TBB) were taken, these biopsies were not counted into consideration for the purposes of this study.
Biopsy-based specificity, sensitivity, PPV, and NPV for detection of each individual technique and their combination were calculated. Only the biopsies confirmed to be positive for premalignant or malignant lesions were taken into calculation of sensitivity and specificity.
Descriptive statistics were generated for all study variables, including mean and standard deviation (SD) for continuous variables and relative frequencies for categorical variables. One sample Kolmogorov-Smirnov test was performed for testing the goodness of fit with the normal distribution. McNemar test was used to compare the diagnostic sensitivity and specificity, and statistically significant differences between categorical variables, sensitivity, specificity, PPV, and NPV of WLB, AFI, NBI, or NBI + AFI findings for detection of precancerous lesions were calculated. All probability values were calculated by assuming a two-tailed α value of 0.05 with confidence intervals at the 95% level. All statistical analyses were performed with SPSS for Windows version 15.0 (SPSS Inc., Chicago, IL, USA).
| Results|| |
Ninety-six patients were included in the study, which comprised 72 (75%) males and 24 (25%) females. Average age of the patients was 56 ± 10 years (range 27-89 years). Majority of the patients were current smokers (67.7%); there were 26% of former smokers and only 6.3% of nonsmokers. Indications for bronchoscopy are given in [Table 2]. There were 32 (33.3%) patients with final diagnosis of squamous cell lung cancer and 12 (12.6%) with adenocarcinoma. In 9 (9.4%) patients, the final diagnosis was dysplasia grade I, 18 (18.8%) patients had dysplasia grade II, 20 (20.8%) patients had confirmed dysplasia grade III, 3 (3.1%) patients had squamous metaplasia only, and 2 (2%) patients were without pathological findings in biopsy. There were no patients with carcinoma in situ (CIS).
Average duration of WLB examination was 9 ± 3 min, while that of AFI and NBI was 10 ± 4 and 8 ± 2 min, respectively. Average duration of the entire examination was 18 ± 5 min. Sensitivity, specificity, PPV, and NPV of WLB were 26.5%, 63.9%, 34.4%, and 54.9%, respectively. Sensitivity of WLB in detection of squamous metaplasia was 27.3%. In detection of dysplasia grade I, II, and III, sensitivity of WLB was 39.5%, 17%, and 24.2%, respectively. AFI demonstrated sensitivity of 52%, specificity of 79.6%, PPV 64.6%, and NPV 69.9%. If analyzed by each type of lesion, sensitivity of AFI was 47.7% for squamous metaplasia, 58.1% for dysplasia grade I, 55.3% for dysplasia grade II, and 48.5% for dysplasia grade III. Sensitivity, specificity, PPV, and NPV of NBI were 66%, 84.6%, 75.4%, and 77.7%, respectively. When calculated by the type of the lesion, NBI showed a sensitivity of 65.9% in detection of squamous metaplasia, for detection of dysplasia grade I the sensitivity was 67.4%, for dysplasia grades II and III the sensitivity was 74.5% and 59.1%, respectively. Combination of techniques showed sensitivity, specificity, PPV, and NPV of 86.1%, 86.8%, 84.6%, and 88%, respectively. Sensitivity of combination in detection of squamous metaplasia was 72.7%. Sensitivity in detection of dysplasia grade I, II, and III was 83.7%, 85.1%, and 89.4%, respectively. Overall sensitivity, specificity, PPV, and NPV are highlighted in [Table 3].
|Table 3: Highlighted sensitivity, specificity, positive predictive value, and negative predictive value of each technique and their combination in detection of precancerous lesions|
Click here to view
Combination of NBI and AFI significantly improves sensitivity when compared to each individual technique (P < 0.001). When specificity is of concern, combination of techniques improves specificity of WLB (P < 0.001) and specificity of AFI (P = 0.03), but it does not have significant influence on specificity of NBI (P = 0.53).
| Discussion|| |
Data presented in this study show superiority of AFI and NBI videobronchoscopy over WLB in detection of precancerous lesions of bronchial mucosa. It is also observed from the data that specificity of AFI remains low and questionable, although one must have in mind that AFI performs better in indications outside of premalignant lesion detection. In pivotal studies, NBI showed superiority over WLB in detection of cancerous and precancerous bronchial lesions. It is also confirmed that NBI improves sensitivity and specificity of WLB along with sensitivity of AFI in detection of these lesions; however, the influence of NBI on specificity of AFI is still questionable. In our study, NBI improved specificity of AFI based on per-lesion and per-biopsy calculations, but larger number of patients would be required to calculate the per-patient efficacy. One of the drawbacks of our study lays in the fact that all examinations were performed by the bronchoscopists highly experienced in both techniques. The major aim of our study was determination of sensitivity, specificity, PPV, and NPV of each individual technique and their combination in order to select the best possible technique for detection of precancerous bronchial lesions. While combination of techniques yields highest sensitivities and specificities, NBI showed sufficient and superior detection of these lesions.
Chen and associates performed a meta-analysis in order to re-examine the diagnostic efficiency of AFB compared with WLB.  The included studies had to have conclusive histology as diagnostic standard for detection of lung cancer and premalignant lesions. Fourteen studies providing 15 sets of data were found to be suitable for analysis. Pooled sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio for AFB were 0.90 (95% CI: 0.84-0.93), 0.56 (95% CI: 0.45-0.66), 2.0 (range 1.7-2.5), and 0.18 (range 0.13-0.26), respectively. Pooled diagnostic odds ratio was found to be 11. On the other hand, pooled sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio for WLB were 0.66 (95% CI: 0.58-0.73), 0.69 (95% CI: 0.57-0.79), 2.1 (1.6-2.9), and 0.50 (0.43-0.58), respectively, while the diagnostic odds ratio was 4. Our study yielded comparable results. For AFI, specificity, sensitivity, PPV, and NPV were 79.6%, 52%, 64.6%, and 69.9%, respectively. Higher specificity obtained in our study could be attributed to high number of patients with invasive bronchial malignancy. Values of sensitivity, specificity, PPV, and NPV are also comparable. In our study, the corresponding values for WLB were 26.5%, 63.9%, 34.4%, and 54.9%, respectively. The authors of meta-analysis concluded that AFB was superior to conventional WLB in detecting lung cancer and preneoplastic lesions. In Sun's meta-analysis,  the main objective was comparison between accuracy of AFB combined with WLB versus WLB alone in the diagnosis of lung cancer. Twenty-one studies involving 3266 patients were ultimately analyzed in Sun's meta-analysis. The pool relative sensitivity on a per-lesion basis to detect intraepithelial neoplasia and invasive cancer was for AFB + WLB 2.04 (95% CI 1.72-2.42) and for WLB alone 1.15 (95% CI 1.05-1.26), and it was statistically significant (P = 0.003). The pool sensitivity on a per-lesion basis of AFB + WLB versus WLB to detect invasive cancer was 94.71% and 88.53%, respectively. The pool specificity on a per-lesion basis of AFB + WLB versus WLB alone was 60.94% and 79.7%, respectively. The main results of this meta-analysis showed that combination of AFB + WLB significantly improves sensitivity to detect intraepithelial neoplasia, even though this advantage seemed much less in detection of invasive lung cancer. Data from our study are consistent with the data presented in Sun's meta-analysis. It must be stated that sensitivity and specificity of AFB in detection of pre-malignant lesions could be highly dependent on several factors such as the type of AFB system, the grade of the lesion, and bronchoscopist's experience. Both sensitivity and specificity of autofluorescence videobronchoscopy show huge differences between the systems and authors. Huge variations in sensitivity and specificity of autofluorescence bronchoscopy are presented in [Table 4].
|Table 4: The sensitivities and specificities of autofluorescence videobronchoscopy in detection of precancerous lesions|
Click here to view
In a study performed by Beamis et al.  AFB (D-light Autofluorescence System, Karl Storz Endoscopy America; Culver City, CA, USA) was used in the detection of class III endobronchial neoplasia (severe dysplasia, CIS, and early invasive lung cancer). The sensitivity of AFB was 61.2% and the sensitivity of WLB was only 10.6% (P < 0.0001 by McNemar test). Specificity was 94.6% under WLB and 75.3% under AFB ( P < 0.0001). PPV for AFB was 22.2% versus 18.4% for WLB ( P = 0.49); NPV for AFB was 94.4% versus 90.2% for WLB ( P < 0.01). This trial undoubtedly proved significant improvement in sensitivity of detecting class III bronchial lesions under AFB examination. One of the most favorable findings is high negative predictive value of AFB in detection of class III bronchial lesions. Similar results are shown in our study.
One of the most important studies about the use of NBI in respiratory endoscopy was published by Vincent et al. in 2009.  The authors investigated whether NBI in conjunction with WLB improves detection of dysplasia and malignancy. Results of the study showed that indication for enrollment in 50% of the patients was known lung cancer. In 32% of the patients, indication was radiological suspicion for lung cancer, undiagnosed parenchymal lung mass was underlying in 36%, while hemoptysis and mediastinal adenopathy were each present in 23% of the patients. There were 64 evaluable biopsies, 22 were control, and 42 were targeted to sites appearing pathological by NBI, WLB, or both. Of the 42 diagnostic biopsies 16 were confirmed to be normal and 26 abnormal. Four biopsies confirmed squamous dysplasia, 9 (41%) were carcinoma, 8 were inflammation, and 5 were non-malignant. This study showed that the NBI is significantly better for detection of dysplasia or cancer ( P < 0.005); it detected five times more dysplasias and carcinomas than WLB. Relative sensitivity ratio for NBI + WLB over WLB alone was calculated to be 1.63, confirming significantly better detection with the addition of NBI. The specificity of NBI + WLB for dysplasia and cancer was 81% versus 64% for WLB alone. Specificity of NBI in our study was 84.6%, while the specificity of WLB was 63.9%, results which are completely comparable to Vincent et al. One of the most recent publications on NBI videobronchoscopy was published by Herth et al.  The authors evaluated the diagnostic yields of NBI individually and in combination with WLB and AFI. The primary aim was to determine the value of NBI over the AFI and WLB, and not to examine the value of bronchoscopy in early lung cancer detection. In Herth et al. study, sensitivity and specificity of WLB were 18% and 88%, respectively. Sensitivity of AFI, NBI, and combination of techniques was 65%, 53%, and 71%, respectively. Specificity of AFI, NBI, and combinations was 40%, 90%, and 40%, respectively. The results of our trial practically confirmed Herth et al. data.
One of the most valuable autofluorescence machines is SAFE-3000 (Pentax, Tokyo Japan). Several trials confirmed that dual imaging system achieves satisfactory sensitivity for the detection of preneoplastic lesions, and improves specificity by allowing targeted biopsy. In a study performed by Lee et al. in patients with known or suspected malignancy, sensitivity of SAFE-3000 system was 86% while specificity reached 94%. The reason why the procedure was shorter in time than in our study could lay in one more additional procedure in our group.  In Divisi's trial,  SAFE-3000 bronchoscopy used "Twin Mode" and "Multiple Image Xposition (MIX)" technologies. The sensitivity of the Twin Mode and MIX techniques in the detection of premalignant and malignant lesions was 96% versus 100%. The specificity was 60% in both of these technologies. This trial confirmed high potential of autofluorescence videobronchoscopy in detection of precancerous lesions. Once again low specificity of autofluorescence, no matter which technique was used, is confirmed. The specificity of NBI alone or in combination with AFI determined in our trial could be the solution for overcoming the pitfall of low specificity of autofluorescence videobronchoscopy.
Large-scale multicenter prospective studies are necessary in order to determine the best bronchoscopic imaging technique for detection of premalignant bronchial epithelial lesions. While waiting for results of such trials, we must rely on available data, which are at least for now suggesting that NBI might be a preferable tool for detection of premalignant bronchial lesions.
| Conclusions|| |
Both techniques, AFI and NBI, show significantly higher sensitivity and specificity in detection of premalignant bronchial lesions, when compared to WLB alone. Combination of techniques is superior over WLB and AFI. However, combination did not demonstrate statistically significant improvement in sensitivity and specificity over NBI. The choice of the technique for improvement in detection of premalignant bronchial lesions mainly depends on availability of technology and experience of the bronchoscopists. If both techniques are available, priority should be given to NBI. If highest rate detection is needed for investigational purposes, techniques should be combined.
| Acknowledgment|| |
The study was supported by the grant of the Serbian Ministry of Science and Technology, grant number 175056.
| References|| |
|1.||Stojsiæ J, Adziæ T, Mariæ D, Subotiæ D, Milovanoviæ I, Milenkoviæ B, et al. Histological types and age distribution of lung cancer operated patients over a 20-year period: A pathohistological based study. Srp Arh Celok Lek 2011;139:619-24. |
|2.||Vrdoljak E, Wojtukiewicz MZ, Pienkowski T, Bodoky G, Berzinec P, Finek J, et al. South Eastern European Research Oncology Group. Cancer epidemiology in central, south and eastern European countries. Croat Med J 2011;52:478-87. |
|3.||Stojsic J, Radojicic J, Markovic J, Milenkovic B, Maric D, Adzic T, et al. Gender and age trends of histological types of lung cancer in a 20-year period: Pathological perspective. J BUON 2010;15:136-40. |
|4.||Stojsic J, Milovanovic I, Radojicic J, Milenkovic B. Lung cancer in women: Histological type and patient age from 1985 to 2005. Med Oncol 2009;26:265-8. |
|5.||Maksimoviæ N, Spanopoulos K. Descriptive-epidemiological characteristics of lung cancer in Serbia. Med Pregl 2008;61:16-21. |
|6.||Zaric B, Perin B, Becker HD, Herth FJ, Eberhardt R, Jovanovic S, et al. Combination of narrow band imaging (NBI) and autofluorescence imaging (AFI) videobronchoscopy in endoscopic assessment of lung cancer extension. Med Oncol 2012;29:1638-42. |
|7.||Zaric B, Perin B. The use of narrow band imaging bronchoscopy in detection of lung cancer. Expert Rev Med Devices 2010;7:395-406. |
|8.||Zaric B, Perin B, Becker HD, Herth FJ, Eberhardt R, Djuric M, et al. Autofluorescence imaging (AFI) videobronchoscopy in detection of lung cancer: From research tool to everyday procedure. Expert Rev Med Devices 2011;8:167-72. |
|9.||Colt HG, Murgu SD. Interventional bronchoscopy from bench to bedside: New techniques for early lung cancer detection. Clin Chest Med 2010;31:29-37. |
|10.||Shibuya K, Nakajima T, Fujiwara T, Chiyo M, Hoshino H, Moriya Y, et al. Narrow band imaging with high-resolution bronchovideoscopy: A new approach for visualizing angiogenesis in squamous cell carcinoma of the lung. Lung Cancer 2010;69:194-202. |
|11.||Yasufuku K. Early diagnosis of lung cancer. Clin Chest Med 2010;31:39-47. |
|12.||Zaric B, Perin B, Stojsic V, Carapic V, Eri Z, Panjkovic M, et al. Relation between vascular patterns visualized by Narrow Band Imaging (NBI) videobronchoscopy and histological type of lung cancer. Med Oncol 2013. in press. |
|13.||Häussinger K, Becker HD, Stanzel F, Kreuzer A, Schmidt B, Strausz J, et al. Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: A European randomized controlled multicenter trial. Thorax 2005;60:496-503. |
|14.||Zaric B, Becker HD, Perin B, Stojanovic G, Jovelic A, Eri Z, et al. Autofluorescence imaging videobrochoscopy improves assessment of tumor margins and affects therapeutic strategy in central lung cancer. JPN J Clin Oncol 2010;40:139-45. |
|15.||Zaric B, Perin B, Jovelic A, Stojanovic G, Ilic MD, Andrijevic I, et al. Influence of narrow band imaging (NBI) videobronchoscopy on the assessment of central lung cancer extension and therapeutic decision. Cancer Invest 2009;27:918-23. |
|16.||Zaric B, Becker HD, Perin B, Jovelic A, Stojanovic G, Ilic MD, et al. Narrow band imaging (NBI) videobronchoscopy improves assessment of lung cancer extension and influences therapeutic strategy. JPN J Clin Oncol 2009;39:657-63. |
|17.||Leng S, Bernauer AM, Hong C, Do KC, Yingling CM, Flores KG, et al. The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas. Clin Cancer Res 2011;17:2014-23. |
|18.||Lantuejoul S, Raynaud C, Salameire D, Gazzeri S, Moro-Sibilot D, Soria JC, et al. Telomere maintenance and DNA damage responses during lung carcinogenesis. Clin Cancer Res 2010;16:2979-88. |
|19.||Gustafson AM, Soldi R, Anderlind C, Scholand MB, Qian J, Zhang X, et al. Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci Transl Med 2010;2:26ra25. |
|20.||McCaughan F, Pole JC, Bankier AT, Konfortov BA, Carroll B, Falzon M, et al. Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer. Am J Respir Crit Care Med 2010;182:83-91. |
|21.||Chen W, Gao X, Tian Q, Chen L. A comparison of autofluorescence bronchoscopy and white light bronchoscopy in detection of lung cancer and preneoplastic lesions: A meta-analysis. Lung Cancer 2011;73:183-8. |
|22.||Sun J, Garfield DH, Lam B, Yan J, Gu A, Shen J, et al. The value of autofluorescence bronchoscopy combined with white light bronchoscopy compared with white light alone in the diagnosis of intraepithelial neoplasia and invasive lung cancer: A meta-analysis. J Thorac Oncol 2011;6:1336-44. |
|23.||Chiyo M, Shibuya K, Hoshino H, Yasufuku K, Sekine Y, Iizasa T, et al. Effective detection of bronchial preinvasive lesions by a new autofluorescence imaging bronchovideoscope system. Lung Cancer 2005;48:307-13. |
|24.||Ueno K, Kusunoki Y, Imamura F, Yoshimura M, Yamamoto S, Uchida J, et al. Clinical experience with autofluorescence imaging system in patients with lung cancers and precancerous lesions. Respiration 2007;74:304-8. |
|25.||Chhajed PN, Shibuya K, Hoshino H, Chiyo M, Yasufuku K, Hiroshima K, et al. A comparison of video and autofluorescence bronchoscopy in patients at high risk of lung cancer. Eur Respir J 2005;25:951-5. |
|26.||Lam B, Wong MP, Fung SL, Lam DC, Wong PC, Mok TY, et al. The clinical value of autofluorescence bronchoscopy for the diagnosis of lung cancer. Eur Respir J 2006;28:916-9. |
|27.||Stringer MR, Moghissi K, Dixon K. Autofluorescence bronchoscopy in volunteer asymptomatic smokers. Photodiagnosis Photodyn Ther 2008;5:148-52. |
|28.||Hanibuchi M, Yano S, Nishioka Y, Miyoshi T, Kondo K, Uehara H, et al. Autofluorescence bronchoscopy, a novel modality for the early detection of bronchial premalignant and malignant lesions. J Med Invest 2007;54:261-6. |
|29.||Beamis JF, Ernst A, Simoff M, Yung R, Mathur P. A multicenter study comparing autofluorescence bronchoscopy to white light bronchoscopy using a non laser light stimulation system. Chest 2004;125:148-9. |
|30.||Ernst A, Simoff MJ, Mathur PN, Yung RC, Beamis JF Jr. D-light autofluorescence in the detection of premalignant airway changes: A muticenter trial. J Bronchology Interv Pulmonol 2005;12:133-8. |
|31.||Herth FJ, Eberhardt R, Anantham D, Gompelmann D, Zakaria MW, Ernst A. Narrow-band imaging bronchoscopy increases the specificity of bronchoscopic early lung cancer detection. J Thorac Oncol 2009;4:1060-5. |
|32.||Lee P, Brokx HA, Postmus PE, Sutedja TG. Dual digital video-autofluorescence imaging for detection of pre-neoplastic lesions. Lung Cancer 2007;58:44-9. |
|33.||Divisi D, Di Tommaso S, De Vico A, Crisci R. Early diagnosis of lung cancer using a SAFE-3000 autofluorescence bronchoscopy. Interact Cardiovasc Thorac Surg 2010;11:740-4. |
|34.||Vincent BD, Fraig M, Silvestri GA. A pilot study of narrow-band imaging compared to white light bronchoscopy for evaluation of normal airways and premalignant and malignant airways disease. Chest 2007;131:1794-9. |
|35.||Cetti EJ, Nicholson AG, Singh S, Wells AU, Shah PL. An evaluation of a videobronchoscopy-based autofluorescence system in lung cancer. Eur Respir J 2010;35:1185-7. |
[Table 1], [Table 2], [Table 3], [Table 4]
|This article has been cited by|
||Comparison of narrow band imaging to white light bronchoscopy for evaluation of histopathological biopsy
| ||Radwa Ahmed Elhefny,Assem Fouad Elessawy,Sameh Samy Abou- Beih,Mohamed Amin Ali,Mona Ibrahim Ahmed |
| ||Egyptian Journal of Chest Diseases and Tuberculosis. 2016; 65(1): 341 |
|[Pubmed] | [DOI]|
||Endobronchial Neurilemmoma Mimicking a Bronchial Polyp
| ||Ryoung Eun Ko,Seung Yong Park,Yeong Hun Choe,So Ri Kim,Heung Bum Lee,Yong Chul Lee,Seoung Ju Park |
| ||Soonchunhyang Medical Science. 2015; 21(2): 176 |
|[Pubmed] | [DOI]|
||High definition bronchoscopy: a randomized exploratory study of diagnostic value compared to standard white light bronchoscopy and autofluorescence bronchoscopy
| ||Erik HFM van der Heijden,Wouter Hoefsloot,Hieronymus WH van Hees,Olga CJ Schuurbiers |
| ||Respiratory Research. 2015; 16(1) |
|[Pubmed] | [DOI]|
||Möglichkeiten der Bronchoskopie in der Onkologie
| ||D. Gompelmann,R. Eberhardt,F. Herth |
| ||Der Onkologe. 2013; 19(11): 993 |
|[Pubmed] | [DOI]|
|| result 1 Document Möglichkeiten der Bronchoskopie in der Onkologie | [Possibilities for bronchoscopy in oncology]
| || Gompelmann, D., Eberhardt, R., Herth, F. |
| ||Source of the Document Onkologe. 2013; |